Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 15
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/1/1988
1.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Breast Cancer Resistant to Conventional Chemotherapy and Hormonal Therapy (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
under 75
EORTC-16864A
Last Modified:
6/1/1988
2.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Gastric Cancer (Summary Last Modified 06/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
75 and under
EORTC-16864B
Last Modified:
3/1/1988
3.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
16 to 74
EORTC-16864C
Last Modified:
3/1/1988
4.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Colorectal Cancer Who Have Received No Prior Chemotherapy (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
75 and under
EORTC-16864D
Last Modified:
3/1/1988
5.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
75 and under
EORTC-16864G
Last Modified:
7/1/1988
6.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 07/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
16 to 75
EORTC-16864E
Last Modified:
4/26/2007
7.
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 06/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
17 to 74
EORTC-16864F
Last Modified:
12/1/1988
8.
Phase I Study of Flavone Acetic Acid in Patients with Advanced Malignancies (Summary Last Modified 12/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
NCI
OSU-85HO193
OSU-IOU-8520, NCI-T85-0168W, T85-0168
Last Modified:
7/10/2006
9.
Phase I Study of Flavone Acetic Acid in Patients with Advanced Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
WRAMC-8504
NCI-85-C-201, NCI-T86-0017N, T86-0017
10.
Phase I Chemotherapy Trial of Flavone Acetic Acid in Patients with Malignant Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
no age specified
NCI
UMCC-8520
NCI-T86-0004W, T86-0004
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute